[Eye complications during use of various medicinal substances with general effects (review of the literature)].
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000324:Adrenocorticotropic Hormone / Q000009:adverse effects; D000493:Allopurinol / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000962:Antimalarials / Q000009:adverse effects; D002301:Cardiac Glycosides / Q000009:adverse effects; D002386:Cataract / Q000139:chemically induced; D002648:Child; D002738:Chloroquine / Q000009:adverse effects; D002746:Chlorpromazine / Q000009:adverse effects; D004837:Epinephrine / Q000009:adverse effects; D004977:Ethambutol / Q000009:adverse effects; D004984:Ethchlorvynol / Q000009:adverse effects; D005128:Eye Diseases / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008916:Miotics / Q000009:adverse effects; D009268:Nalidixic Acid / Q000009:adverse effects; D010710:Phosphates / Q000009:adverse effects; D010862:Pilocarpine / Q000009:adverse effects; D011804:Quinolines / Q000009:adverse effects; D012162:Retinal Degeneration / Q000139:chemically induced; D014859:Warfarin / Q000009:adverse effects
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D000962:Antimalarials; D002301:Cardiac Glycosides; D008916:Miotics; D010710:Phosphates; D011804:Quinolines; D010862:Pilocarpine; D009268:Nalidixic Acid; D014859:Warfarin; D000493:Allopurinol; D004984:Ethchlorvynol; D002738:Chloroquine; D004977:Ethambutol; D000324:Adrenocorticotropic Hormone; D002746:Chlorpromazine; D004837:Epinephrine
Oslozhneniia so storony glaz pri primenenii nekotorykh lekarstvennykh veshchestv obshchego deĭstviia.